Copyright
©The Author(s) 2015.
World J Gastroenterol. Feb 14, 2015; 21(6): 1838-1844
Published online Feb 14, 2015. doi: 10.3748/wjg.v21.i6.1838
Published online Feb 14, 2015. doi: 10.3748/wjg.v21.i6.1838
Figure 1 Immunohistochemical analysis of fibroblast growth factor receptor 4 protein expression (× 200).
A: High expression; B: Low expression.
Figure 2 Significant difference was found between patients with high and low fibroblast growth factor receptor 4 protein expression after stratified Kaplan-Meier survival analysis.
A: Patients with tumor size ≤ 3 cm; B: Patients with well-differentiated gastric cancer; C: Patients with gastric cancer classified as stage T1 or T2.
- Citation: Chen H, Shen DP, Zhang ZZ, Liu JH, Shen YY, Ni XZ. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer. World J Gastroenterol 2015; 21(6): 1838-1844
- URL: https://www.wjgnet.com/1007-9327/full/v21/i6/1838.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i6.1838